Results 191 to 200 of about 178,919 (340)

P2X₇ nucleotide receptor activation enhances IFNγ‐induced type II nitric oxide synthase activity in BV‐2 microglial cells [PDF]

, 2003
Fernand‐Pierre Gendron, Małgorzata Chalimoniuk, Joanna B. Strosznajder, Siming Shen, Fernando A. González, Gary A. Weisman, Grace Y. Sun   +6 more
openalex   +1 more source

Identification of genetic markers associated with coronary artery disease in Pakistani Pashtun population: A case-control association study. [PDF]

Medicine (Baltimore)
Jan A, Ullah A, Khattak M, Shah WA, Akbar R, Nahla UA.   +5 more
europepmc   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Non‐NF‐κB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells [PDF]

, 2000
Hanfang Zhang, Xingwu Teng, Connie Snead, John D. Catravas   +3 more
openalex   +1 more source

Association of the Endothelial Nitric Oxide Synthase (eNOS) G894T Gene Polymorphism With Type 2 Diabetes Mellitus in a Tunisian Population. [PDF]

Endocrinol Diabetes Metab
Ba A, Ayoub M, Aboulkacem S, Belhedi M, Aouni Z, Mazigh C.   +5 more
europepmc   +1 more source

Harnessing Piezoelectric Biomaterials for Pathogenic Eradication and Tissue Regeneration

Exploration, EarlyView.
This review highlights recent advances in piezoelectric biomaterials for antibacterial therapy and tissue regeneration, discussing material classifications, catalytic mechanisms, property enhancements, biomedical applications, and future challenges in clinical translation.
Wenxuan Mao, Xiaoye Li, Ao He, Meng Ding, Yu Zhang, Zhuo Dai, Qiang Li, Weijun Xiu, Yanling Hu, Yongbin Mou, Dongliang Yang, Heng Dong   +11 more
wiley   +1 more source

Cardioprotection with Angiotensin Converting Enzyme Inhibitor and Angiotensin II Type 1 Receptor Antagonist Is Not Abolished by Nitric Oxide Synthase Inhibitor in Ischemia-Reperfused Rabbit Hearts.

, 2001
Hitoshi Kawabata, Teruhiko Ryomoto, Kinji Ishikawa   +2 more
openalex   +2 more sources

A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea‐pig suprachiasmatic nucleus [PDF]

, 2001
Sarah J. Starkey, Andrea L Grant, Russell M. Hagan   +2 more
openalex   +1 more source

Cardamonin Commands the Colonic Metabolite Columbianetin Acetate to Compete Against LPS in Binding HMGB1 in the Kidney, Preventing Lipopolysaccharide‐Induced Renal Tubular Pyroptosis

Food Frontiers, EarlyView.
Cardamonin upregulate sd the intestinal metabolite columbianetin acetate, which competitively bound HMGB1 to prevent LPS‐induced renal tubular cell pyroptosis (the figure is created with BioRender). ABSTRACT Sepsis‐associated acute kidney injury (SA‐AKI) results in high mortality due to the lack of effective interventions. The current study reports the
Zihui Zhou, Xuechun Sun, Jian Zhou, Huali Meng, Pengfei Fan, Yufeng Chu, Hao Wu   +6 more
wiley   +1 more source

Endothelial Nitric Oxide Synthase Inhibits G_12/13and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor [PDF]

, 2008
Hiroyuki Suzuki, Keita Kimura, Heigoro Shirai, Kunie Eguchi, Sadaharu Higuchi, Akinari Hinoki, Kazuhiro Ishimaru, Eugen Brailoiu, Danny N. Dhanasekaran, Laura N. Stemmle, Timothy A. Fields, Gerald D. Frank, Michael V. Autieri, Satoru Eguchi   +13 more
openalex   +1 more source